Cookson Peirce & Co’s Bristol-Myers Squibb BMY Stock Holding History

Cookson Peirce & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$573K	Buy	9,943 +424	+4%	+$24.3K	0.02%	242
2026 Q1	$577K	Buy	+9,519	New	+$555K	0.02%	225
2023 Q3	–	Sell	-11,360	Closed	-$726K	–	208
2023 Q2	$726K	Sell	11,360 -111,244	-91%	-$7.46M	0.04%	117
2023 Q1	$8.5M	Buy	122,604 +1,147	+0.9%	+$80.9K	0.54%	64
2022 Q4	$8.74M	Buy	121,457 +101,616	+512%	+$7.66M	0.57%	55
2022 Q3	$1.41M	Buy	19,841 +1,334	+7%	+$96.8K	0.1%	92
2022 Q2	$1.43M	Buy	18,507 +11,743	+174%	+$894K	0.1%	92
2022 Q1	$494K	Buy	+6,764	New	+$454K	0.03%	143
2014 Q2	–	Sell	-8,750	Closed	-$455K	–	137
2014 Q1	$455K	Buy	8,750 +270	+3%	+$14.4K	0.11%	111
2013 Q4	$451K	Buy	8,480 +410	+5%	+$20.9K	0.12%	101
2013 Q3	$374K	Buy	8,070 +3,320	+70%	+$146K	0.1%	88
2013 Q2	$213K	Buy	+4,750	New	+$206K	0.06%	89

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cookson Peirce & Co's BMY Position: Q2 2026 in Review

Cookson Peirce & Co increased its Bristol-Myers Squibb (BMY) stake by 4.5% in Q2 2026, buying an estimated $24.3K and bringing the position to 9,943 shares worth $573K. The position accounts for 0.02% of the portfolio, ranked #242.

Cookson Peirce & Co first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $8.74M in Q4 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cookson Peirce & Co held 9,943 shares of Bristol-Myers Squibb worth $573K as of Q2 2026.
Cookson Peirce & Co bought 424 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.3K.
Bristol-Myers Squibb made up 0.02% of Cookson Peirce & Co's portfolio in Q2 2026, its #242 holding.
Cookson Peirce & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
Cookson Peirce & Co's Bristol-Myers Squibb position peaked at $8.74M in Q4 2022.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.